Integrated Wealth Management (Palm Desert)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Integrated Wealth Management (Palm Desert)'s NVS Position: Q1 2017 in Review
Integrated Wealth Management (Palm Desert) reduced its Novartis (NVS) stake by 1.7% in Q1 2017, selling an estimated $4.13K and leaving 3,554 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #219.
Integrated Wealth Management (Palm Desert) first reported a position in NVS in Q1 2015 and has held it in 9 quarters since. The position peaked at $416K in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.
- Integrated Wealth Management (Palm Desert) held 3,554 shares of Novartis worth $237K as of Q1 2017.
- Integrated Wealth Management (Palm Desert) sold 62 Novartis shares in Q1 2017, an estimated $4.13K.
- Novartis made up 0.08% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #219 holding.
- Integrated Wealth Management (Palm Desert) first reported a position in Novartis in Q1 2015 and has held it in 9 quarters since.
- Integrated Wealth Management (Palm Desert)'s Novartis position peaked at $416K in Q2 2015.
- 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.
Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.